Right ventricular ischemia in patients with primary pulmonary hypertension

被引:172
作者
Gómez, A
Bialostozky, D
Zajarias, A
Santos, E
Palomar, A
Martínez, ML
Sandoval, J
机构
[1] Inst Nacl Cardiol Ignacio Chavez, Cardiopulm Dept, Mexico City, DF, Mexico
[2] Inst Nacl Cardiol Ignacio Chavez, Dept Nucl Cardiol, Mexico City, DF, Mexico
关键词
D O I
10.1016/S0735-1097(01)01496-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES The goal of this study was to determine whether right ventricular (RV) ischemia is a contributory factor in the development of RV dysfunction in patients with primary pulmonary hypertension (PPH). BACKGROUND Patients with advanced PPH develop RV dysfunction, characterized by a decreased cardiac output, increased right atrial pressure (RAP) and/or elevated RV end-diastolic pressure, which progresses to heart failure and death. The cause of this dysfunction is unknown. Right ventricular ischemia may play a role in its development. METHODS From 1992 to 1999, a prospective study involving 23 patients with PPH at the Instituto Nacional de Cardiologia "Ignacio Chavez" (Mexico City, Mexico) was undertaken. These patients were evaluated clinically and further studied by echocardiography, right heart catheterization and stress myocardial scintigraphy using technetium 99m sestamibi. RESULTS Nine patients of 23 were found to have scintigraphic images consistent with RV ischemia. Significant correlation was found between RV ischemia obtained through myocardial perfusion scintigraphy and elevation of RV end-diastolic pressure (p < 0.001), elevation of RAP (p < 0.037) and a decrease in mixed venous oxygen saturation (p < 0.0001). No other clinical or hemodynamic variables showed a significant correlation with RV ischemia. CONCLUSIONS A direct correlation exists between RV ischemia, as determined by myocardial scintigraphy, and hemodynamic alterations suggestive of RV dysfunction in patients with PPH. (C) 2001 by the American College of Cardiology.
引用
收藏
页码:1137 / 1142
页数:6
相关论文
共 29 条
  • [1] IMPORTANCE OF ANGIOTENSIN-CONVERTING ENZYME IN PULMONARY-HYPERTENSION
    ABRAHAM, WT
    RAYNOLDS, MV
    GOTTSCHALL, B
    BADESCH, DB
    WYNNE, KM
    GROVES, BM
    LOWES, BD
    BRISTOW, MR
    PERRYMAN, MB
    VOELKEL, NF
    [J]. CARDIOLOGY, 1995, 86 : 9 - 15
  • [2] EFFECTS OF HYPERTROPHY ON THE CORONARY CIRCULATION
    BACHE, RJ
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 1988, 30 (06) : 403 - 440
  • [3] BRISTOW MR, 1990, CIRCULATION, V82, P12
  • [4] BRUCE R A, 1963, Pediatrics, V32, P742
  • [5] Lipid mediator dysregulation in primary pulmonary hypertension
    Christman, BW
    [J]. CHEST, 1998, 114 (03) : 205S - 207S
  • [6] SURVIVAL IN PATIENTS WITH PRIMARY PULMONARY-HYPERTENSION - RESULTS FROM A NATIONAL PROSPECTIVE REGISTRY
    DALONZO, GE
    BARST, RJ
    AYRES, SM
    BERGOFSKY, EH
    BRUNDAGE, BH
    DETRE, KM
    FISHMAN, AP
    GOLDRING, RM
    GROVES, BM
    KERNIS, JT
    LEVY, PS
    PIETRA, GG
    REID, LM
    REEVES, JT
    RICH, S
    VREIM, CE
    WILLIAMS, GW
    WU, M
    [J]. ANNALS OF INTERNAL MEDICINE, 1991, 115 (05) : 343 - 349
  • [7] DEPUEY EG, 1991, J NUCL MED, V32, P1199
  • [8] DEPUEY EG, 1995, CARDIAC SPECT IMAGIN, P124
  • [9] EXERCISE STANDARDS - A STATEMENT FOR HEALTH-CARE PROFESSIONALS FROM THE AMERICAN-HEART-ASSOCIATION
    FLETCHER, GF
    BALADY, G
    FROELICHER, VF
    HARTLEY, LH
    HASKELL, WL
    POLLOCK, ML
    [J]. CIRCULATION, 1995, 91 (02) : 580 - 615
  • [10] GERMANO G, 1995, J NUCL MED, V36, P2138